Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical ...

If you are glued to the Olympic coverage as I am, you are seeing the commercial from Eli Lilly and Company. Lilly's advertisement uses the scientific method as a narrative frame, drawing a par ...

Over the ensuing five hours, the NIH leadership and MAHA Institute moderators found many areas of common ground: anger over ...

All opinions, columns and letters reflect the views of the individual writer and not necessarily those of the IDS or its staffers. Whether your New Year’s resolution was to lock in this semester, ...

Noubar Afeyan is founder and CEO of Flagship Pioneering. He is also cofounder and board chair of Moderna. Massachusetts has long been a hotbed for innovation. Rebellious ideas — channeled through the ...

In October 1945, George Orwell responded to a letter from Mr J. Stewart Cook in the leftwing weekly newspaper Tribune calling ...

The Trump administration has revoked a scientific finding that climate change is a danger to public health, an idea that ...

What Noubar Afeyan eloquently describes in his Jan. 29 op-ed, in defense of the scientific method, “Science at risk: Massachusetts must lead the fight for facts,” is what fascism looks like, plain and ...

As India’s pharmaceutical industry moves towards becoming a 500 billion dollars global powerhouse by 2047, a new report ...

In prophetic words for today’s AI age, in 2014, he urged the Church and the political world to remember that human beings may ...

New Jersey policymakers should act to ensure that junk science has no place in our legal system. Patients deserve better.

High-entropy alloys are promising advanced materials for demanding applications, but discovering useful compositions is difficult and expensive due to the vast number of possible element combinations.